Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Purity | ≥98% |
---|---|
Formula | C18H18O4 |
Formula Wt. | 298.33 |
IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
Appearance | White Crystal Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Carotene pigment found in red and green fruits ...
Steroidal alkaloid found in Fritillaria; M2 mAC...
Endogenous opioid peptide; δOR and μOR agonis...
β-adrenergic antagonist, voltage-gated Na+ and...
Imidazole; 14-α demethylase inhibitor.
Pyrrolidone; NMDA and mGluR5 agonist, N-type an...
Cysteine derivative found in Allium; NMDA NR2A/...
Peptide, oxytocin analog; potential OXTR agonis...
Cell-penetrating peptide, carries large conjuga...
PLK1 inhibitor.
Chalcone; SIRT activator, GABA-A positive modul...
Triterpene saponin found in Bupleurum.
Aldosterone antagonist.
Mycotoxin produced by Fusarium; ER agonist.
Cannabinoid receptor 2 selective agonist.
β-lactam cephalosporin; penicillin binding pro...
Dihydropyridine; L-type Ca2+ channel blocker.
Rapamycin impurity
Calcium channel blocker.
β-lactamase inhibitor.